The ongoing COVID-19 pandemic has spared none. But it has been more brutal to people who are in an immunocompromised state. For example, cancer patients have weakened immune system. This makes them all the more susceptible to COVID-19 infection, especially when they visit hospital for follow-up or clinical procedures.
Given this, even cancer hospitals in India are prioritizing patients that require cancer curative therapy. The patients who stand to benefit substantially from treatment are being prioritized in current pandemic situation. The patients who are expected to have only marginal benefit from the treatment, are being deferred right now owing to the risks involved.
As a result, there is a transformation taking place in how post-acute care is delivered to cancer patients away from hospital. Supportive cancer care at home is one approach that is gaining popularity.
The clinical needs of a cancer patient are very unique. They require a more complex care to be delivered to them. Let’s look at what should constitute a cancer care at home program.
When we initiated cancer care for a 49 years old female patient in Bangalore, our Care Doctor followed the care protocol defined by the oncologist, initiated RT feeds, monitored her body’s response to RT feeds, and constantly interacted with the patient’s family to help them understand what’s happening.
Read how our doctor collaborated with a stomach cancer patient’s onco-specialist to offer symptom relief to patient at home.
However, this is done after qualifying patient’s case under the ongoing COVID pandemic and setting up adequate precautions. These steps are taken to minimize the exposure of the patient to possible infections.
We ensured our 74-years old stage 4 liver cancer patient avoided hospital visits by offering him clinical interventions at home. We enabled timely access to medical expertise and physical presence of a skilled medic for clinical interventions in his time of need.
In a retrospective cohort study conducted in 2019, it was established that Ubiqare’s team had managed 96% of clinical episodes at home for patients. For more details on the types of episodes managed, download the study paper.
Find out more about our Cancer Care at Home service.